Synthesis of 1L-chiro-inositol 2,3,5-trisphosphorothioate, the first partial agonist at the platelet myo-inositol 1,4,5-trisphosphate receptor.

The synthesis of L-chiro-inositol 2,3,5-trisphosphorothioate, a novel analogue of the second messenger D-myo-inositol 1,4,5-trisphosphate has been accomplished from the natural product L-quebrachitol. Phosphitylation of (-)-1L-1,4,6-tri-O-benzoyl-chiro-inositol obtained from L-quebrachitol followed by sulfoxidation of the products gave (-)-1L-1,4,6-tri-O-benzoyl-chiro-inositol 2,3,5-tris[di(2-cyanoethyl) phosphorothioate], which was deblocked using sodium in liquid ammonia to give 1L-(-)-chiro-inositol 2,3,5-trisphosphorothioate. 1L-chiro-Inositol 2,3,5-trisphosphorothioate is a partial agonist in the release of intracellular Ca2+ from saponin-permeabilised platelets and is both a key tool for pharmacological dissection of the polyphosphoinositide pathway of cellular signalling and a lead compound for the design of small molecule Ins(1,4,5)P3 receptor antagonists.

[1]  B. Potter,et al.  Synthesis from quebrachitol of 1L-chiro-inositol 2,3,5-trisphosphate, an inhibitor of the enzymes of 1D-myo-inositol 1,4,5-trisphosphate metabolism , 1992 .

[2]  H. Feinberg,et al.  Inositol 1,4,5-trisphosphate-induced calcium release from platelet plasma membrane vesicles. , 1988, Biochemical and biophysical research communications.

[3]  R Jacob,et al.  Calcium oscillations in electrically non-excitable cells. , 1990, Biochimica et biophysica acta.

[4]  J. Westwick,et al.  The relationship between cytosolic Ca2+, sn-1,2-diacylglycerol and inositol 1,4,5-trisphosphate elevation in platelet-activating-factor-stimulated rabbit platelets. Influence of protein kinase C on production of signal molecules. , 1991, The Biochemical journal.

[5]  B. Potter,et al.  Stereospecific mobilization of intracellular Ca2+ by inositol 1,4,5-triphosphate. Comparison with inositol 1,4,5-trisphosphorothioate and inositol 1,3,4-trisphosphate. , 1988, The Biochemical journal.

[6]  K. Authi.  Localisation of the [32P]IP3 binding site on human platelet intracellular membranes isolated by high‐voltage free‐flow electrophoresis , 1992, FEBS letters.

[7]  N. J. Noble,et al.  Total synthesis of myo-inositol-1-phosphate-4,5-pyrophosphate, a novel second messenger analogue, via myo-inositol-1-phosphate-4,5-bisphosphorothioate , 1992 .

[8]  L. Brass,et al.  Inositol 1,4,5-triphosphate-induced granule secretion in platelets. Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein-dependent mechanism distinct from that of thrombin. , 1987, The Journal of clinical investigation.

[9]  N. J. Noble,et al.  Synthesis of (±)-myo-inositol 1,4,5-trisphosphate and the novel analogue (±)-myo-inositol 1,4-bisphosphate 5-phosphorothioate , 1992 .

[10]  S. Muallem,et al.  Hormone-evoked calcium release from intracellular stores is a quantal process. , 1989, The Journal of biological chemistry.

[11]  C. Taylor,et al.  The size of inositol 1,4,5-trisphosphate-sensitive Ca2+ stores depends on inositol 1,4,5-trisphosphate concentration. , 1990, The Biochemical journal.

[12]  B. Potter,et al.  Molecular recognition of inositol polyphosphates by intracellular receptors and metabolic enzymes. , 1989, Trends in pharmacological sciences.

[13]  H. Wässle,et al.  Pharmacology of GABA receptor CI− channels in rat retinal bipolar cells , 1993, Nature.

[14]  A. P. Briggs.  A MODIFICATION OF THE BELL-DOISY PHOSPHATE METHOD , 1922 .

[15]  B. Jastorff,et al.  [15] cAMP analog antagonists of cAMP action , 1988 .

[16]  B. Potter,et al.  Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor. , 1993, Molecular pharmacology.

[17]  K. Authi,et al.  Inositol 1,4,5-trisphosphate-induced release of sequestered Ca2+ from highly purified human platelet intracellular membranes. , 1985, The Biochemical journal.

[18]  B. Potter,et al.  Myo-inositol(1,4,5)trisphosphorothioate binds to specific [3H]inositol(1,4,5)trisphosphate sites in rat cerebellum and is resistant to 5-phosphatase. , 1988, European journal of pharmacology.

[19]  Colin W. Taylor,et al.  Structure and function of inositol triphosphate receptors , 1991 .

[20]  B. Potter,et al.  Interactions between inositol tris- and tetrakis-phosphates. Effects on intracellular Ca2+ mobilization in SH-SY5Y cells. , 1991, The Biochemical journal.

[21]  C. Taylor,et al.  Liver inositol, 1,4,5-trisphosphate-binding sites are the Ca2(+)-mobilizing receptors. , 1990, The Biochemical journal.

[22]  B. Potter,et al.  myo-Inositol 1,4,5-trisphosphorothioate: a novel analogue of a biological second messenger , 1987 .

[23]  F. Rouxel,et al.  Characterization of a rapidly dissociating inositol 1,4,5-trisphosphate-binding site in liver membranes. , 1992, The Journal of biological chemistry.

[24]  J. Westwick,et al.  Myo-inositol 1,4,6-trisphosphate: A new synthetic Ca2+-mobilising inositol phosphate , 1993 .

[25]  B. Potter,et al.  Recent advances in the chemistry and biochemistry of inositol phosphates of biological interest. , 1990, Natural product reports.

[26]  W. Stec,et al.  Inhibition of cAMP-dependent protein kinase by adenosine cyclic 3'-, 5'-phosphorodithioate, a second cAMP antagonist. , 1988, The Journal of biological chemistry.

[27]  S. Snyder,et al.  Inositol phosphate receptors and calcium disposition in the brain , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[28]  B. Potter,et al.  3-position modification of myo-inositol 1,4,5-trisphosphate: consequences for intracellular Ca2+ mobilisation and enzyme recognition. , 1992, European journal of pharmacology.